More SEC Filings
View Older Stories View Newer Stories-
Form 8-K Glucotrack, Inc. For: May 15
-
Form SCHEDULE 13G/A Opus Genetics, Inc. Filed by: Nantahala Capital Management, LLC
-
Form 6-K SMX (Security Matters) For: May 15
-
Form 424B3 TOP SHIPS INC.
-
Form 13F-NT Coatue Structured Fund For: Mar 31
-
Form 13F-NT Ancora Alternatives LLC For: Mar 31
-
Form 424B2 UBS AG
-
Form NT 10-Q MANGOCEUTICALS, INC. For: Mar 31
-
Form 8-K NOVANTA INC For: May 15
-
Form 13F-HR Ampersand Capital Group, For: Mar 31
-
Form S-8 Regional Management Corp
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form 424H WELLS FARGO COMMERCIAL
-
Form 8-K DATA I/O CORP For: May 14
-
Form 13F-HR WHITEBOX ADVISORS LLC For: Mar 31
-
Form 13F-HR RPD Fund Management LLC For: Mar 31
-
Form 6-K CDT Environmental Techno For: May 15
-
Form 424B2 UBS AG
-
Form 13F-NT Wagner Thomas For: Mar 31
-
Form SCHEDULE 13G/A KIORA PHARMACEUTICALS Filed by: Nantahala Capital Management, LLC
-
Form 424B2 UBS AG
-
Form SCHEDULE 13G/A NOODLES & Co Filed by: Nantahala Capital Management, LLC
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form 8-K Cooper-Standard Holdings For: May 14
-
Form 424B2 UBS AG
-
Form 4 NEWMONT Corp /DE/ For: May 13 Filed by: CLARK MAURA J
-
Form SCHEDULE 13G MetaVia Inc. Filed by: Alyeska Investment Group, L.P.
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form 25-NSE Cantor Equity Partners Filed by: Nasdaq Stock Market LLC
-
Form 3 Allegiant Travel CO For: May 13 Filed by: VOGEL JENNIFER L
-
Form SCHEDULE 13G/A DEEP FISSION, INC. Filed by: Tompkins Mark N.
-
Form 424B2 HSBC USA INC /MD/
-
Form 4 AMKOR TECHNOLOGY, INC. For: May 13 Filed by: KIM SUSAN Y
-
Form 424B2 UBS AG
-
Form SCHEDULE 13G SUTRO BIOPHARMA, INC. Filed by: Samsara BioCapital, L.P.
-
Form 144 Lifeway Foods, Inc. Filed by: SMOLYANSKY EDWARD
-
Form 13F-NT COATUE EARLY STAGE FUND For: Mar 31
-
Form SCHEDULE 13G PELOTON INTERACTIVE, Filed by: Nantahala Capital Management, LLC
-
Form SCHEDULE 13G Xilio Therapeutics, Inc. Filed by: ORBIMED ADVISORS LLC
-
Form SCHEDULE 13G/A Quince Therapeutics, Filed by: Nantahala Capital Management, LLC
-
Form 424B2 UBS AG
-
Form SCHEDULE 13G/A Cineverse Corp. Filed by: CORSAIR CAPITAL MANAGEMENT, L.P.
-
Form SCHEDULE 13G/A Fossil Group, Inc. Filed by: Nantahala Capital Management, LLC
-
Form 13F-NT Hahn Financial Group For: Mar 31
-
Form 424B2 UBS AG
-
Form SCHEDULE 13G Merlin, Inc. Filed by: Alyeska Investment Group, L.P.
